Breast Cancer
The latest information on BRCA, chemotherapy, mammography, mastectomy, and more, drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.
SUMMARY AND COMMENT
Should Women Stop HT Temporarily Before Undergoing Screening Mammography?Free
- June 25, 2009
- Andrew M. Kaunitz, MD
- Women's Health
Suspending HT for 1 or 2 months did not lower mammography recall rates, but did increase likelihood of experiencing vasomotor symptoms.
- Reviewing:
- Buist DSM et al. Ann Intern Med 2009 Jun 2; 150:752
SUMMARY AND COMMENT
Still Looking for Effective Nonhormonal Hot Flash Therapies
- June 25, 2009
- Robert W. Rebar, MD
- Women's Health
Acupuncture, Chinese herbs, and other nonestrogenic therapies resulted in modest improvements in hot flash frequency; head-to-head comparisons with estrogen are lacking.
- Reviewing:
- Borud EK et al. Menopause 2009 May/Jun; 16:484
ASCO 2009 Report: Breast CancerFree
- June 16, 2009
- William J. Gradishar, MD
- Oncology and Hematology
New trials in triple-negative and HER2-negative disease
SUMMARY AND COMMENT
Are Anthracyclines Justified for Breast Cancer?
- June 2, 2009
- William J. Gradishar, MD
- Oncology and Hematology
Most patients are not likely to benefit from anthracycline-based adjuvant chemotherapy.
- Reviewing:
- O’Malley FP et al. J Natl Cancer Inst 2009 May 6; 101:644
SUMMARY AND COMMENT
Stiff-Person Syndrome with Anti-Amphiphysin Antibodies
- June 2, 2009
- Steven A. Greenberg, MD
- Neurology
A large study of patients with stiff-person syndrome refines the clinical features of patients with anti-amphiphysin antibodies, highlighting the very high frequency of breast cancer.
- Reviewing:
- Murinson BB and Guarnaccia JB. Neurology 2008 Dec 9; 71:1955
SUMMARY AND COMMENT
Biopsies of New Metastatic Lesions in Breast Cancer
- May 26, 2009
- William J. Gradishar, MD
- Oncology and Hematology
Knowledge of discordance in molecular markers between primary tumors and metastatic lesions altered disease management in 20% of patients.
- Reviewing:
- Simmons C et al. Ann Oncol 2009 Mar 18
SUMMARY AND COMMENT
Brain Metastases in Triple-Negative Breast Cancer
- May 26, 2009
- William J. Gradishar, MD
- Oncology and Hematology
Cumulative incidence at 5 years was nearly 10%.
- Reviewing:
- Dawood S et al. Ann Oncol 2009 Apr; 20:621
FEATURE
Vitamin D and HealthFree
- May 22, 2009
- Dermatology
Do we have enough? How do we get more? What systems are affected?
SUMMARY AND COMMENT
Adjuvant Chemotherapy in Older Patients with Breast CancerFree
- May 13, 2009
- William J. Gradishar, MD
- Oncology and Hematology
Capecitabine was inferior to standard chemotherapy.
- Reviewing:
- Muss HB et al. N Engl J Med 2009 May 14; 360:2055
SUMMARY AND COMMENT
Is Prophylactic Bilateral Oophorectomy Associated with All-Cause Mortality?
- May 7, 2009
- Robert W. Rebar, MD
- General Medicine
Bilateral oophorectomy was associated with elevated hazard ratios for all-cause mortality, fatal plus nonfatal coronary heart disease, and stroke.
- Reviewing:
- Parker WH et al. Obstet Gynecol 2009 May; 113:1027
